View Article

  • Digital Solutions for Drug Recall and Banned Drug Management

  • P. R. Pote Patil College of Pharmacy, Kathora Road, Amravati-444604, Maharashtra, India.

Abstract

Drug recalls are crucial for protecting public health when pharmaceutical products are found to be defective, contaminated, mislabeled, or unsafe. The traditional drug recall process involve fragmented information systems, manual communication, delayed identification of affected products, and difficulties in tracking products across the supply chain. These can increase the time required to identify, notify, and remove potentially harmful medicines from the market. This study an explores the role of digital solutions for improving drug recall management through different technologies such as blockchain, AI/ML system, serialization, electronic health record, traceability system, recall notification system. Digital platforms can support real-time communication among manufacturers, distributors, healthcare providers, regulatory authorities, pharmacies, and patients. Digital technologies can improve the speed, accuracy, transparency, and effectiveness of drug recalls, while reducing risk of human error. A framework for implementing digital drug recall solutions can strengthen pharmaceutical supply-chain safety and contribute to improve patient protection and public health outcomes.

Keywords

Drug Recall, Traceability, Artificial Intelligence, Blockchain Technology, Recall Notification System

Introduction

× Popup Image

A Drug Recall is a approach to return the entire batch product due to safety and quality issue or any deficiency in product [1]. The reason for recall can be unapproved drug, microbial contamination in formulation, incorrect information on packaging, visible particulates, suspected to serious risk related to drug [2].

Types of Recall

Class I recall: the situation in which drug cause serious health consequences.

Class II recall: the situation in which drug cause temporary or reversible health consequences.

Class III recall: the situation where drug not cause any health consequences [3].

Level of Recall

Consumer level: these are end user like patients, hospitals, doctors.

Retail level: these are intermediate between wholesale and end user like pharmacies, clinics, dispensing doctors.

Wholesale level: these are distribution between manufacture and retail. Every class I recall is carried out at all the levels of recall, class II recall is carried out at wholesale and retail levels while class III recall is carried out at only wholesale level [4].

Impact on Public and Pharma

On public: Recall increase the patient anxiety, can cause adverse health outcome, also treatment can disturb. This can show in pantoprazole and valsartan recall which had created a temporary gap in medication, which further managed by giving alternating therapies.

On Pharma: Recall can cause drug shortage also may disturb the supply chain, reputation and trust on company may damage, financial and legal liabilities being faced by organization along with the regulatory inspections [5].

Objective of Drug Recall

The primary objective of drug recall is to protect public from defective product present in market. Recall efficiency not only depend on withdrawal rate but also on implementation of corrective action, communication efficiency, traceability in supply chain [1].

Current Drug Recall System

Recall Process

1.Notification and response: the regulatory body is notified about drug, firm explains the reason of recall of drug.

2.Tracking: the drug is recalled at all levels by determining recall strategy across the supply chain. Different means of media and communication is also used for tracking at different levels of distribution.

3.Compliance and Reporting: the regulatory body check status reports to determine effectiveness of recall.

4.Post Recall Procedure: the firm generate final report through recall coordination committee which includes cause, corrective action, effectiveness of recall [6].

Limitations

1.Weak supply chain Traceability: some businesses still depend on manual documentation and traditional systems which make batch identification difficult and slow. This is the major challenge in drug recall process.

2.Lack of Strong legal enforceability: Indian regulatory has limited powers due to which recall execution may delay. The developed countries like USA, other countries have strict law and heavy penalties for any type of non-compliance that is a reason of mandatory recalls.

3.Limited Technological Integration: lack of digital technology integration affects transparency, slow recall communication, reduce regulatory efficiency.

4. Fragmented Regulatory Structure: In India, CDSCO is regulatory authority at center with the coordination of other state authorities. So wherever recall or drug banned is imposed there is communication gap and other enforcement activity results in delayed recall. This is also create problem in recall system.

5. Inadequate Post-Recall Monitoring: Regulatory authorities face this challenge after product withdrawal, the lack of centralized systems of monitoring limited the recall actions evaluation due to which defective drug product are move across the supply chain.

6. Delayed detection and Recall response: In some cases, the recall is initiated after reporting of any adverse effect of drug. This can happen because of inactive inspections, lack of laboratories, poor coordination.

7. Growing challenges due to online medicine distribution: The new age of digitalization has increase the new challenges, the distribution of medicines has become a strong with online era. But the existing recall framework has limited rules and guidelines with online distribution which is not capable of participating in recall monitoring [7].

Pharmaceutical Traceability in Drug Recall

Pharmaceutical track and trace systems (PTTS) is a solution to prevent the false products from entering the market. This system can mandate the scanning of product at every point from entry to dispatch [8]. Track and trace technology helps in tracking the present and previous locations throughout the supply chain. It has also significance in financial and e-commerce sector, but this technology is not fully adopted across the supply chain [9].

Benefits of Traceability

a. Timely Product Recalls: Product are recalled as soon as possible from clinics, hospitals, patients, through generating digital ID for product which can tagged every information.

b. Cold Chain Monitoring: Temperature sensitive product can be monitored which can also be checked by patient also. These can improve the patient confidence and trust, patients can report if any sub-standard storage of product may happen.

c. Electronic Product Information: Patient can directly access the product or drug information on their hands. Patients can directly access the alerts and notices of recall and product information.

d. Improved supply chain resilience: Companies can tackle the supply chain problem by end-to-end traceability. Industries can make strategies of retrieval and locate the product [10].

DIGITAL TECHNOLOGIES FOR DRUG RECALL

Serialization

Serialization means assigning of unique identifier (serial number) to individual package to product. This identifier can be barcode, 2D matrix or machine readable format which helps in track and trace product through supply chain. While manufacturing the product packaging is printed with unique identifier, the whole serialization data is then uploaded to secure databases. At each stage the product is scanned and verified, ensure authenticity and traceability [11].

AI/ML System

The integration of Artificial intelligence with serialization help in managing recall management.AI and machine learning (ML) can analyze large amount of data to identify unusual patterns and quality problems at early stage. This help industries to detect potential risk associated with patient safety and risk. Techniques such as convolutional neural network and recurrent neural network helps in studying parameters with different factors helps to identify relation with product defect. Machine Learning models such as Natural Language Processing (NLP) can also analyze adverse event reports, investigation documentation, regulatory reports. AI predictive analytics can monitor environmental conditions such as temperature, humidity if any changes occur the system generate the alerts to teams about affected batch. Different ML Techniques, like support vector machines, gradient boosting algorithms, can help in assessing risk associated with individual batches and helping in identifying products that may require testing or investigation [12].

Digital Complaints and Adverse event Integration

Digital complaints of patient help in providing as a source of information. Patients frequently describe their symptoms in normal verbal language rather than standard medicinal terminology. So by integrating digital complaint information with pharmacovigilance or ADR database can provide additional safety information regarding patient health status. It can also help in support continuous drug safety monitoring. Patients complaints can be collected through mobile applications, electronic records, patients portal, and other digital platforms. Natural Language Processing (NLP) which is ML technique, converts raw complaint data into structural information such as drug name, adverse event, severity. These data can be combined with adverse-event database to identify recurring patterns or safety signals [13].

Such example of adverse event database is FDA Adverse Event Monitoring System (AEMS). This is unified platform provide data quality and consistency through disciplined protocols. It has given strength to safety surveillance by optimizing digital tools, special workflow systems. AEMS also serve as centralized platform for managing patient complaints. This platform can help in safety monitoring, trend identification across various drug or formulations, also decision making to protect public health by integrating various data and tools [14].

Real Time Recall Notification System

Whenever concern occurs on marketed product, it is necessary to supply this information to hospitals, clinics, patients, pharmacists so to action should be taken timely. Despite this, patients and physicians not get timely recall information which leaving the healthcare system unable to stop product impact. To solve this problem, FDA had developed the prototype technology for patients and sector so to automatically gives notification of drug recall or banning of drug to health care portals. This allowing the patients, health care professionals, industries to connected with each other and to improve the public health. Whenever firms, manufacturers or FDA initiate the recalls the consumer gets notified about the new recall of batch no., drug name, brand, other information. This system allowed timely, fully automated communication regarding recall [15].

Such example of this technology can be National Institutes of Health-sponsored Informatics for Integrating Biology and Bedside (i2b2) platform which help in identify patient quickly and direct notification to their health care portals that is Electronic Health Records (EHR) [16].

Blockchain Technology for Drug Recall

Blockchain technology is emerging technology in pharmaceutical industry. This technology can solve the problem of security of data and transaction while recalling product. The steps involved in product recall can be:

1.Synergistic decision: The product recall is initiated either by regulatory or manufacturer. The recall strategy is made like level of recall, traceability of product, notification of recall, risk analysis of recall. Recall decisions can be taken by analyze OOS, any adverse effect reported, any packaging defect is identified.

2.Quality issue detection: The smart contract is analytical model which indicated to laboratory about issue. Whatever record are produced that are stored in blockchain network.

3.OOS/OOT investigation: After the completion of OOS/OOT study the smart contract will decide the next decisions should taken on the basis of outcome.

Advantages of this technology:

a. Traceability of product across supply chain

b. Security is improved

c. Increase in confidence of consumer

d. Regulatory Compliance

e. Improvised communication while sharing data [17].

Role of Cybersecurity and Data Integrity

Data Integrity refers to reliability, honesty, consistency and accurate of information generated and processed during pharmaceutical processes. The integrity of data is essential in for ensuring safety, efficacy, quality of product. Failures in data integrity including incomplete batch documentation, manipulated analytical records may compromise in product safety. The increase in digitalization across the pharmaceutical manufacturing is making new issues. Industries must ensure the original, accurate, legible electronic record should be established in relation with data integrity principles. Although these technologies are helping in managing data and efficiency, but it also increases the risk of cyberattacks which can lead to disturb the activities and decisions related to product [18].

Cybersecurity plays a vital role in healthcare infrastructures include medical devices, operating systems, which can expose to security threats. Cybersecurity incompetence may affect device performance, safety risks such problem require updates, corrective action. By strengthening the cybersecurity protocols, medical devices can be protected in complex healthcare systems. Cybersecurity is becoming essential part in safety rather than just technical concern [19].

Regulatory Framework for Drug Recall

The regulation of drug recall comes under Drug and Cosmetics Act, 1940 and Rules 1945. Although there is no standalone statute for drug recall but are different provisions in legal framework to support the recall. The Central Drugs Standard Control Organization (CDSCO) and Drug Controller General of India (DCGI) supervise the recall monitoring. Also State Drug Control Authorities are responsible for enforcement in regional level, the coordination between both central and state authorities are very much important for recall situations. In 2012, CDSCO have introduced “Guidelines on Recall and Rapid Alert System for Drugs” for initiation of recall, recall classification, information regarding product recall. Overall, the regulatory framework for drug recall has improved over time, but it faces some challenges. Strengthening of recall framework not only for public health but also maintaining confidence in Indian Pharmaceutical products at global level is must [7].

U.S.FDA Recall Framework

US.FDA is one of most followed and strict regulatory in world. Recall framework of FDA is based on risk which applies strategy in all levels of recall. The framework is supported with pharmacovigilance programs such as MedWatch and FAERS. Digital approaches for surveillance like internet search engine are increasingly used in recall signals. Despite this, FDA face criticism over delayed action, improper communication which may compromise with public health and recall procedure [18].

CONCLUSION

Digital Solutions can help in improving and enhancing the drug recall management by providing patient safety through timely recall pharmaceutical product from market. Technologies such as AI/ML, pharmaceutical track and trace system, Blockchain technology, digital complaints, real time recall notification system, help in identifying quality issue, track product throughout the supply chain and notify hospitals, pharmacies and patients quickly, also preparing recall documentation. These technologies and solutions reduce response time, enhance traceability, minimize errors, increase transparency, and regulatory compliance. Adoption of these technologies drug recall gets faster, accurate, efficient which build patient trust on healthcare system.

REFERENCES

  1. Nagaich U, Sadhna D. Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history. Int J Pharm Investig. 2015 Jan-Mar;5 (1):13-9. doi: 10.4103/2230-973X.147222. PMID: 25599028; PMCID: PMC4286830.
  2. E. Gopinath, R.S. Bhadauria, Arpit Jain. Pharmaceutical Product Recall: An Overview for Handling and Decision Making. Research J. Pharm. and Tech. 4 (9): Sept. 2011; Page 1333-1339. Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2011-4-9-1
  3. 3.US FDA Recalls Background and Definition [Internet][cited 2026 Aug 29]. Available from: https://www.fda.gov/safety/industry-guidance-recalls/recalls-background-and-definitions
  4. Pangavhane PS, Shinde SP, Bhusal SB. Recall of Drug in India and United Kingdom: A Comparative Review. Int. J. Drug Reg. Affairs [Internet]. 2024 Dec15 [cited 2024 Dec 15]; 12 (4):97-102. Available from: http://ijdra.com/index.php/journal/article/view/726 DOI: https://doi.org/10.22270/ijdra.v12i4.726
  5. "Recent Analysis of Major Indian Drug Safety Alerts and Recalls: Impact on Pharmacovigilance Policies and Consumer Protection", JAAFR - JOURNAL OF ADVANCE AND FUTURE RESEARCH (www.JAAFR.org), ISSN:2984-889X, Vol.3, Issue 12, page no.461-486, December-2025, Available :https://rjwave.org/JAAFR/papers/JAAFR2512169.pdf
  6. Vvss, Rohit & Veluchuri, Jaya & Adhikari, Sravya & Indukuri, Harika. (2020). An Overview on Pharmaceutical Drug Recalls. 16-22.[Internet] [cited 2026 Sep 02].
  7. Singh, Irom & Hussain, Mr. (2026). Drug Recall System in India: Regulatory Framework and Challenges. International Scientific Journal of Engineering and Management. 05. 1-9. 10.55041/ISJEM07661.
  8. Kootstra J, Kleinhout-Vliek T. Implementing pharmaceutical track-and trace systems: a realist review. BMJ Global Health 2021;6:e003755. doi:10.1136/ bmjgh-2020-003755
  9. Madalsa Kumar (2023). Emerging Digital Technologies for Pharmaceutical Drug Traceability. Universal Journal of Pharmacy and Pharmacology, 2 (1), 34-40. https://doi.org/10.31586/ujpp.2023.794
  10. Sim C, Zhang H, Chang ML. Improving End-to-End Traceability and Pharma Supply Chain Resilience using Blockchain. Blockchain Healthc Today. 2022 Aug 12;5. doi: 10.30953/bhty.v5.231. PMID: 36779026; PMCID: PMC9907421.
  11. Serialization and its role in managing Drug Recalls and Returns https://www.advanco.com/article/serialization-and-its-role-in-managing-drug-recalls-and-returns/ [Internet] [cited 2026 Sep 09].
  12. Karanam, Sasikiran. (2025). AI-Driven Predictive Analytics For Medicinal Product Recall Management: Enhancing Traceability And Regulatory Compliance. Journal of International Crisis and Risk Communication Research. 415-422. 10.63278/jicrcr.vi.3379.
  13. Usui M, Aramaki E, Iwao T, Wakamiya S, Sakamoto T, Mochizuki M Extraction and Standardization of Patient Complaints from Electronic Medication Histories for Pharmacovigilance: Natural Language Processing Analysis in Japanese
  14. U.S. Food and Drug Administration. New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS) [Internet] [cited 2026 Sep 22].
  15. Gadgil M, Pavlakos R, Carini S, Turner B, Elder I, Hess W, Houle L, Huff L, Johanson E, Ramos-Izquierdo C, Liang D, Ogonowski P, Phipps J, Peryea T, Sim I. Automating Individualized Notification of Drug Recalls to Patients: Complex Challenges and Qualitative Evaluation. JMIRx Med. 2026 Jan 13;7:e68345. doi: 10.2196/68345. PMID: 41529108; PMCID: PMC12798837.
  16. Mendelson MM, Zachariah JP, de Ferranti SD, Bickel JP. Leveraging electronic health records to notify pediatric patients of a drug recall. JAMA Pediatr. 2013 Dec;167 (12):1170-1. doi: 10.1001/jamapediatrics.2013.2755. PMID: 24165895; PMCID: PMC4130461.
  17. Khyati Shah, Dhara Patel, Grishma Patel, Dhananjay Meshram, Drug Recall Management for Pharmaceutical Industry from Blockchain Perspective, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 8, 1276-1287. https://doi.org/10.5281/zenodo.16812751
  18. Kumar S, Chaturvedi S. Drug Recall Systems in Pharmaceutical Regulation: Regulatory Frameworks, Procedures, and Global Perspectives. Drugs and Drug Candidates. 2026; 5 (3):39. https://doi.org/10.3390/ddc5030039
  19. Menon V. Cybersecurity breaches in medical devices: analyzing FDA safety communications in response to patient security concerns. Front Digit Health. 2026 Mar 30;8:1701551. doi: 10.3389/fdgth.2026.1701551. PMID: 41982627; PMCID: PMC13070934.

Reference

  1. Nagaich U, Sadhna D. Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history. Int J Pharm Investig. 2015 Jan-Mar;5 (1):13-9. doi: 10.4103/2230-973X.147222. PMID: 25599028; PMCID: PMC4286830.
  2. E. Gopinath, R.S. Bhadauria, Arpit Jain. Pharmaceutical Product Recall: An Overview for Handling and Decision Making. Research J. Pharm. and Tech. 4 (9): Sept. 2011; Page 1333-1339. Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2011-4-9-1
  3. 3.US FDA Recalls Background and Definition [Internet][cited 2026 Aug 29]. Available from: https://www.fda.gov/safety/industry-guidance-recalls/recalls-background-and-definitions
  4. Pangavhane PS, Shinde SP, Bhusal SB. Recall of Drug in India and United Kingdom: A Comparative Review. Int. J. Drug Reg. Affairs [Internet]. 2024 Dec15 [cited 2024 Dec 15]; 12 (4):97-102. Available from: http://ijdra.com/index.php/journal/article/view/726 DOI: https://doi.org/10.22270/ijdra.v12i4.726
  5. "Recent Analysis of Major Indian Drug Safety Alerts and Recalls: Impact on Pharmacovigilance Policies and Consumer Protection", JAAFR - JOURNAL OF ADVANCE AND FUTURE RESEARCH (www.JAAFR.org), ISSN:2984-889X, Vol.3, Issue 12, page no.461-486, December-2025, Available :https://rjwave.org/JAAFR/papers/JAAFR2512169.pdf
  6. Vvss, Rohit & Veluchuri, Jaya & Adhikari, Sravya & Indukuri, Harika. (2020). An Overview on Pharmaceutical Drug Recalls. 16-22.[Internet] [cited 2026 Sep 02].
  7. Singh, Irom & Hussain, Mr. (2026). Drug Recall System in India: Regulatory Framework and Challenges. International Scientific Journal of Engineering and Management. 05. 1-9. 10.55041/ISJEM07661.
  8. Kootstra J, Kleinhout-Vliek T. Implementing pharmaceutical track-and trace systems: a realist review. BMJ Global Health 2021;6:e003755. doi:10.1136/ bmjgh-2020-003755
  9. Madalsa Kumar (2023). Emerging Digital Technologies for Pharmaceutical Drug Traceability. Universal Journal of Pharmacy and Pharmacology, 2 (1), 34-40. https://doi.org/10.31586/ujpp.2023.794
  10. Sim C, Zhang H, Chang ML. Improving End-to-End Traceability and Pharma Supply Chain Resilience using Blockchain. Blockchain Healthc Today. 2022 Aug 12;5. doi: 10.30953/bhty.v5.231. PMID: 36779026; PMCID: PMC9907421.
  11. Serialization and its role in managing Drug Recalls and Returns https://www.advanco.com/article/serialization-and-its-role-in-managing-drug-recalls-and-returns/ [Internet] [cited 2026 Sep 09].
  12. Karanam, Sasikiran. (2025). AI-Driven Predictive Analytics For Medicinal Product Recall Management: Enhancing Traceability And Regulatory Compliance. Journal of International Crisis and Risk Communication Research. 415-422. 10.63278/jicrcr.vi.3379.
  13. Usui M, Aramaki E, Iwao T, Wakamiya S, Sakamoto T, Mochizuki M Extraction and Standardization of Patient Complaints from Electronic Medication Histories for Pharmacovigilance: Natural Language Processing Analysis in Japanese
  14. U.S. Food and Drug Administration. New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS) [Internet] [cited 2026 Sep 22].
  15. Gadgil M, Pavlakos R, Carini S, Turner B, Elder I, Hess W, Houle L, Huff L, Johanson E, Ramos-Izquierdo C, Liang D, Ogonowski P, Phipps J, Peryea T, Sim I. Automating Individualized Notification of Drug Recalls to Patients: Complex Challenges and Qualitative Evaluation. JMIRx Med. 2026 Jan 13;7:e68345. doi: 10.2196/68345. PMID: 41529108; PMCID: PMC12798837.
  16. Mendelson MM, Zachariah JP, de Ferranti SD, Bickel JP. Leveraging electronic health records to notify pediatric patients of a drug recall. JAMA Pediatr. 2013 Dec;167 (12):1170-1. doi: 10.1001/jamapediatrics.2013.2755. PMID: 24165895; PMCID: PMC4130461.
  17. Khyati Shah, Dhara Patel, Grishma Patel, Dhananjay Meshram, Drug Recall Management for Pharmaceutical Industry from Blockchain Perspective, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 8, 1276-1287. https://doi.org/10.5281/zenodo.16812751
  18. Kumar S, Chaturvedi S. Drug Recall Systems in Pharmaceutical Regulation: Regulatory Frameworks, Procedures, and Global Perspectives. Drugs and Drug Candidates. 2026; 5 (3):39. https://doi.org/10.3390/ddc5030039
  19. Menon V. Cybersecurity breaches in medical devices: analyzing FDA safety communications in response to patient security concerns. Front Digit Health. 2026 Mar 30;8:1701551. doi: 10.3389/fdgth.2026.1701551. PMID: 41982627; PMCID: PMC13070934.

Photo
Vinay Kamnani
Corresponding author

P. R. Pote Patil College of Pharmacy, Kathora Road, Amravati-444604, Maharashtra, India.

Photo
Abhijeet Welankiwar
Co-author

P. R. Pote Patil College of Pharmacy, Kathora Road, Amravati-444604, Maharashtra, India.

Vinay Kamnani, Abhijeet Welankiwar, Digital Solutions for Drug Recall and Banned Drug Management, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 11, 3546-3551. https://doi.org/10.5281/zenodo.24393711

More related articles
Formulation and Evaluation of Anti-Microbial Herba...
Shivalingappa Hasabi, Ramesh Kinhal, Preeti Meti Veeresh G. Hanag...
A Review on Phytochemical Constituents of Tridax P...
Sakshi Thorat, Nitin Neharkar, Shambala Taur...
Transdermal Drug Delivery Systems: Recent Advances...
Suyog Vishe, Monika Vinchu, Harshali Shelar, Avadhoot Partole, Ad...
Artificial Intelligence and the Changing Role of Pharmacists: From Medication Di...
Divya Raj, Tessy S., Parthan Reghu, Kiran Kuriakose, Jeeva Rajan, Athulya P....
Analytical Method Development and Validation of a Stability Indicating RP-HPLC M...
Nakerekanti Geetha, Vijaya Kuchana, Pasupuleti Sunitha, G. Kalyani...
Pharmacological Evaluation of Anti-Obesity Activity with Etanolic Extract of Hyg...
Dr. A. Srinivasa Rao, M. Manusha, Dr. A. V. Kishore Babu...
Related Articles
Bioadhesive Drug Delivery Systems for Prolonged Residence Time: Emerging Polymer...
Aditi Tarmale, Vinaya Vekhande, Namrata Sabale, Manasi Padwal, Gouri Gavhane, Dhanashree Chandgir...
Eye Flue Conjuctivities: A Review...
Anurag Jangam, Vinay Janrav, Mahajan Rohit, Krushna Jethe, Kalyani Gosavi...
Regulatory Landscape of E-Cigarettes Across the World: A Review...
Rucha Jani, Vishva Dhotre, Shwet Patel, Shreya Rathod, Misari Patel, Krima Patel...
Phytochemical Diversity and Combined Therapeutic Potential of Cucumis sativus L....
Saloni Talekar, Sakshi Pise, Harshada Wadile, Dr. Vinod Pawar, Dr. Pravin Utekar...
Formulation and Evaluation of Anti-Microbial Herbal Cream...
Shivalingappa Hasabi, Ramesh Kinhal, Preeti Meti Veeresh G. Hanagal, Kiran Sutar, Pradeep Mirje...
More related articles
Formulation and Evaluation of Anti-Microbial Herbal Cream...
Shivalingappa Hasabi, Ramesh Kinhal, Preeti Meti Veeresh G. Hanagal, Kiran Sutar, Pradeep Mirje...
Transdermal Drug Delivery Systems: Recent Advances, Evaluation Techniques, and C...
Suyog Vishe, Monika Vinchu, Harshali Shelar, Avadhoot Partole, Aditya Jamghare, Sahil Shirose...
Formulation and Evaluation of Anti-Microbial Herbal Cream...
Shivalingappa Hasabi, Ramesh Kinhal, Preeti Meti Veeresh G. Hanagal, Kiran Sutar, Pradeep Mirje...
Transdermal Drug Delivery Systems: Recent Advances, Evaluation Techniques, and C...
Suyog Vishe, Monika Vinchu, Harshali Shelar, Avadhoot Partole, Aditya Jamghare, Sahil Shirose...